Your Article Summary
See Latest ArticlesMediGene Concludes Agreement with Juste for the Commercialization of Veregen in Spain and Portugal
MediGene, 06/24/09
MediGene AG has entered into a marketing partnership with the Spanish company Juste S.A.Q.F. for the commercialization of Veregen ointment in Spain and Portugal. Juste, a family-owned specialty pharma company, will promote and distribute the drug for the treatment of genital warts. Depending on specified milestones and sales targets achieved, MediGene is entitled to successive payments totalling up to 2,550,000 euro. MediGene will supply Juste with the finished product, and will receive royalties on the sales revenue for Veregen.
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Watson Receives FTC Clearance for Arrow Acquisition
Watson Pharmaceuticals, 12/03/09
Watson Completes Acquisition of Arrow Group
Watson Pharmaceuticals, 12/03/09
GSK completes extension of strategic collaboration with Aspen
GlaxoSmithKline, 12/02/09